Following President Donald Trump’s January 21, 2025 Executive Order (EO) titled, “Ending Illegal Discrimination and Restoring Merit-Based Opportunity,” recent federal developments may impact how companies approach their review of existing diversity, equity, and inclusion (DEI)

Continue Reading President Trump’s DEI Executive Orders: Recent developments for employers to know


The US Food and Drug Administration (FDA) recently issued its draft guidance, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations on January 7, 2025. The draft guidance provides insights on how FDA

Continue Reading FDA issues Artificial Intelligence-Enabled Device Software Functions draft guidance


Time is running out for Corporate Transparency Act (CTA) compliance. The law, which became effective on January 1, 2024, requires certain entities – or “reporting companies” – to disclose information about their beneficial ownership to

Continue Reading ‘Tis the season and past time for a ho-ho-hum approach to Corporate Transparency Act reporting deadline

On September 28, 2024, California enacted SB 1120, which regulates the use of artificial intelligence (AI), an algorithm, or “other software tool” in utilization review and utilization management (UR/UM) functions by healthcare service plans (HCSPs)

Continue Reading California implements new AI and software regulations for insurers